Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
We report a patient with amelanotic melanoma of the esophagus who responded well to nivolumab treatment. Shortly after the tumor response, vitiligo was found on the patient ’s forearms. This case suggests that the occurrence of vitiligo is associated with a favorable response to nivolumab treatment for amelanotic melanoma.
Source: International Cancer Conference Journal - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Conferences | Esophagus Cancer | Melanoma | Skin | Skin Cancer | Vitiligo